Anticonvulsant hypersensitivity syndrome - Two case reports and a review;Antikonvulsiva hypersensitivitäts-syndrom zwei fallbeschreibungen und eine übersicht

Praxis

Volumn 88, Issue 41, 1999, Pages 1660-1666

  Ronsdorf, A ^a   Schlienger, R G ^a   Haefeli, W E ^a   Martin Facklam, M ^a   Schoenenberger, R A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Adverse drug reaction; Anticonvulsants; Hypersensitivity; Syndrome

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPYRETIC ANALGESIC AGENT; CARBAMAZEPINE; DIAZEPAM; METHYLPREDNISOLONE; PHENOBARBITAL; PHENYTOIN; PREDNISONE;

ADULT; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EPILEPSY; FEMALE; HUMAN; REVIEW; ANAMNESIS; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; PATHOGENESIS; SKIN MANIFESTATION;

ADULT; ANTICONVULSANTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EPILEPSY; FEMALE; HUMANS;

EID: 0033533672     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Schnyder B., Zanni M.P., Pichler W.J.: Medikamenteninduzierte Hypersensitivtätssyndrome. Schweiz. Med. Wschr. 127, 355-9, 1997.
2. Rieder M.J., Uetrecht J., Shear N.H., Cannon M., Miller M., Spielberg S.P.: Diagnosis of sulfonamide hypersensitivity reactions by in-vitro «rechallenge » with hydroxilamine metabolites. Ann. Intern. Med. 110, 286-9, 1989.
3. Arellano F., Sacristán J.A.: Allopurinol hypersensitivity syndrome: a review. Ann. Pharmacother. 19, 337-43, 1993.
4. Knowles S.R., Gupta A.K., Shear N.H., Sauder D.: Azathioprine hypersensitivity-like reactions - a case report and review of the literature. Clin. Exp. Dermatol. 20, 353-6, 1995.
5. Prussick R., Shear N.H.: Dapsone hypersensitivity syndrome. J. Am. Acad. Dermatol. 35, 346-9, 1996.
6. Knowles S.R., Shapiro L., Shear N.H.: Serious adverse drug reactions induced by minocycline. Report of 13 patients and review of the literature. Arch. Dermatol. 132, 934-9, 1996.
7. Shear N.H., Spielberg S.P.: Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk. J. Clin. Invest. 82, 1826-32, 1988.
8. Vittorio C.C., Muglia J.J.: Anticonvulsant hypersensitivity syndrome. Arch. Intern. Med. 155, 2285-90, 1995.
9. Schlienger R.G., Knowles S.R., Shear N.H.: Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 51, 1172-5, 1998.
10. Kleier R.S., Breneman D.L., Boiko S.: Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch. Dermatol. 127, 1361-4, 1991.
11. Schlienger R.G., Shear N.H.: Antiepileptic drug hypersensitivity syndrome. Epilepsia 39 (Suppl. 7), S3-7, 1998.
12. Parker W.A., Shearer C.A.: Phenytoin hepatotoxicity: A case report and review. Neurology 29, 175-8, 1979.
13. Haruda R.: Phenytoin hypersensitivity: 38 cases. Neurology 29, 1480-5, 1979.
14. Chang D., Shear N.: Cutaneous reactions to anticonvulsants. Sem. Neurol. 12, 329-37, 1992.
15. Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Naldi L., Roujeau J.-C.: Clinical classifications of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch. Dermatol. 129, 92-6, 1993.
16. Roujeau J.C., Stern R.S.: Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331, 1272-85, 1994.
17. Gupta A., Eggo M.C., Uetrecht J.P., Cribb A.E., Danemann D., et al.: Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin. Pharmacol. Ther. 51, 56-67, 1992.
18. Powers N.G., Carson N.H.: Idiosyncratic reactions to phenytoin. Clin. Pediatr. 25, 120-4, 1987.
19. Handfield-Jones S.E., Jenkins R.E., Whittaker S.J., Besse C.P., McGibbon D.H.: The anticonvulsant hypersensitivity syndrome. Br. J. Dermatol. 129, 175-7, 1993.
20. Flowers F.P., Araujo O.E., Hamm K.A.: Phenytoin hypersensitivity syndrome. J. Emerg. Med. 5, 103-8, 1987.
21. Stein J., Petrides P.E.: Antikonvulsiva Hypersensitivitäts-Syndrom. Dtsch. Med. Wschr. 122, 314-5, 1997.
22. Licata A.L., Louis E.D.: Anticonvulsant hypersensitivity syndrome. Comprehens. Ther. 22, 152-5, 1996.
23. Leeder J.S.: Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 39 (Suppl. 7), S8-16, 1998.
24. Gleichmann H.: Studies on the mechanism of drug sensitization: T-cell dependent popliteal lymph node reaction to diphenylhydantoin. Clin. Immunol. Immunopathol. 18, 203-11, 1981.
25. Tennis P., Stern R.S.: Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. Neurology 49, 542-6, 1997.
26. Schlienger R.G., Oh P.I., Knowles S.R., Shear N.H.: Quantifying the costs of serious adverse drug reactions to antiepileptic drugs. Epilepsia 39 (Suppl. 7), S27-32, 1998.
27. Sontheimer R.D., Houpt K.R.: DIDMOHS: A proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch. Dermatol. 134, 874-5, 1998.
28. Griebel M.L.: Acute management of hypersensitivity reactions and seizures. Epilepsia 39 (Suppl. 7), S17-21, 1998.
29. De Vriese A.S.P., Van Rentgerheim D.M., De Cuyper C.A., Hindryckx P.H.F., Matthys E.G.J., et al.: Carbamazepine hypersensitivity syndrome: Report of cases and review of the literature. Medicine 74, 144-51, 1995.
30. Hyson C., Sadler M.: Cross sensitivity of skin rashes with antiepileptic drugs. Can. J. Neurol. Sci. 24, 245-9, 1997.
31. Allredge B.K., Knutsen A.P., Ferriero D.: Antiepileptic drug hypersensitivity syndrome. Pediatr. Neurol. 10, 169-71, 1994.
32. Plantin P., Cartier H., Le Bihan G., Clouard .P, Lellouche F., et al.: Syndrome d'hypersensibilité médicamenteuse au cours d'un traitement par acide valproïque. Presse Med. 24, 1624, 1995.